Akso Health (AHG) Invested Capital (2019 - 2026)

Akso Health (AHG) has reported Invested Capital for 8 consecutive years, with $350527.0 the latest figure, recorded in Q1 2026.

• Quarterly Invested Capital fell 82.47% year-over-year to $350527.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (down 59.52% YoY) and the FY2026 annual result came in at $350527.0, down 82.47% from the prior year.
• Invested Capital eased to $350527.0 in Q1 2026 per AHG's latest filing, from $2.0 million in the prior quarter.
• Over the last five years, Invested Capital for AHG reached as high as $37.2 million in Q1 2022 and fell as low as $350527.0 in Q1 2026.
• A 5-year average of $8.3 million and a median of $2.0 million in 2024 frame the typical range for Invested Capital.
• The largest YoY upside for Invested Capital was 1153.04% in 2022 against a maximum downside of 100.0% in 2022.
• Year by year, Invested Capital stood at $9.7 million in 2022, then advanced by 0.0% to $9.7 million in 2023, then plunged by 79.35% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025, then plunged by 82.47% to $350527.0 in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $350527.0, $2.0 million, and $2.0 million for Q1 2026, Q3 2025, and Q1 2025 respectively.